These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19020667)

  • 61. The position of the fourth segment of domain 4 determines status of the inactivation gate in Na+ channels.
    Yang YC; Kuo CC
    J Neurosci; 2003 Jun; 23(12):4922-30. PubMed ID: 12832514
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Sodium channel activation gating is affected by substitutions of voltage sensor positive charges in all four domains.
    Kontis KJ; Rounaghi A; Goldin AL
    J Gen Physiol; 1997 Oct; 110(4):391-401. PubMed ID: 9379171
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Heteropoda toxin 2 is a gating modifier toxin specific for voltage-gated K+ channels of the Kv4 family.
    Zarayskiy VV; Balasubramanian G; Bondarenko VE; Morales MJ
    Toxicon; 2005 Mar; 45(4):431-42. PubMed ID: 15733564
    [TBL] [Abstract][Full Text] [Related]  

  • 64. KCND2 variants associated with global developmental delay differentially impair Kv4.2 channel gating.
    Zhang Y; Tachtsidis G; Schob C; Koko M; Hedrich UBS; Lerche H; Lemke JR; van Haeringen A; Ruivenkamp C; Prescott T; Tveten K; Gerstner T; Pruniski B; DiTroia S; VanNoy GE; Rehm HL; McLaughlin H; Bolz HJ; Zechner U; Bryant E; McDonough T; Kindler S; Bähring R
    Hum Mol Genet; 2021 Nov; 30(23):2300-2314. PubMed ID: 34245260
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The S4-S5 linker couples voltage sensing and activation of pacemaker channels.
    Chen J; Mitcheson JS; Tristani-Firouzi M; Lin M; Sanguinetti MC
    Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11277-82. PubMed ID: 11553787
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Niflumic acid alters gating of HCN2 pacemaker channels by interaction with the outer region of S4 voltage sensing domains.
    Cheng L; Sanguinetti MC
    Mol Pharmacol; 2009 May; 75(5):1210-21. PubMed ID: 19218366
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inhibition of the Kv4 (Shal) family of transient K+ currents by arachidonic acid.
    Villarroel A; Schwarz TL
    J Neurosci; 1996 Feb; 16(3):1016-25. PubMed ID: 8558229
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Kv4.2 autism and epilepsy mutation enhances inactivation of closed channels but impairs access to inactivated state after opening.
    Lin MA; Cannon SC; Papazian DM
    Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3559-E3568. PubMed ID: 29581270
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The aromatic cluster in KCHIP1b affects Kv4 inactivation gating.
    Van Hoorick D; Raes A; Snyders DJ
    J Physiol; 2007 Sep; 583(Pt 3):959-69. PubMed ID: 17640927
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Time- and voltage-dependent modulation of a Kv1.4 channel by a beta-subunit (Kv beta 3) cloned from ferret ventricle.
    Castellino RC; Morales MJ; Strauss HC; Rasmusson RL
    Am J Physiol; 1995 Jul; 269(1 Pt 2):H385-91. PubMed ID: 7631872
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A direct demonstration of closed-state inactivation of K+ channels at low pH.
    Claydon TW; Vaid M; Rezazadeh S; Kwan DC; Kehl SJ; Fedida D
    J Gen Physiol; 2007 May; 129(5):437-55. PubMed ID: 17470663
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Modeling-independent elucidation of inactivation pathways in recombinant and native A-type Kv channels.
    Fineberg JD; Ritter DM; Covarrubias M
    J Gen Physiol; 2012 Nov; 140(5):513-27. PubMed ID: 23109714
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Riluzole inhibits Kv4.2 channels acting on the closed and closed inactivated states.
    Pacheco-Rojas DO; Delgado-Ramírez M; Villatoro-Gómez K; Moreno-Galindo EG; Rodríguez-Menchaca AA; Sánchez-Chapula JA; Ferrer T
    Eur J Pharmacol; 2021 May; 899():174026. PubMed ID: 33722592
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hydrophobic substitution mutations in the S4 sequence alter voltage-dependent gating in Shaker K+ channels.
    Lopez GA; Jan YN; Jan LY
    Neuron; 1991 Aug; 7(2):327-36. PubMed ID: 1873032
    [TBL] [Abstract][Full Text] [Related]  

  • 75. minK-related peptide 1 associates with Kv4.2 and modulates its gating function: potential role as beta subunit of cardiac transient outward channel?
    Zhang M; Jiang M; Tseng GN
    Circ Res; 2001 May; 88(10):1012-9. PubMed ID: 11375270
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Two arginines in the cytoplasmic C-terminal domain are essential for voltage-dependent regulation of A-type K+ current in the Kv4 channel subfamily.
    Hatano N; Ohya S; Muraki K; Clark RB; Giles WR; Imaizumi Y
    J Biol Chem; 2004 Feb; 279(7):5450-9. PubMed ID: 14645239
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Molecular basis of gating charge immobilization in Shaker potassium channels.
    Bezanilla F; Perozo E; Papazian DM; Stefani E
    Science; 1991 Nov; 254(5032):679-83. PubMed ID: 1948047
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Reverse use dependence of Kv4.2 blockade by 4-aminopyridine.
    Tseng GN; Jiang M; Yao JA
    J Pharmacol Exp Ther; 1996 Nov; 279(2):865-76. PubMed ID: 8930194
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Conserved Kv4 N-terminal domain critical for effects of Kv channel-interacting protein 2.2 on channel expression and gating.
    Bähring R; Dannenberg J; Peters HC; Leicher T; Pongs O; Isbrandt D
    J Biol Chem; 2001 Jun; 276(26):23888-94. PubMed ID: 11287421
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Regulation of mammalian Shaker-related K+ channels: evidence for non-conducting closed and non-conducting inactivated states.
    Jäger H; Rauer H; Nguyen AN; Aiyar J; Chandy KG; Grissmer S
    J Physiol; 1998 Jan; 506 ( Pt 2)(Pt 2):291-301. PubMed ID: 9490854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.